Dr. Nurilign Assefa Bulcha, MD

Dr. Bulcha practices at Beauregard Health System in Deridder, Louisiana, part of Beauregard Parish Police Jury.

Dr. Bulcha's NPI, 1811309511, was assigned on May 29, 2014. Dr. Bulcha's Texas license number on file is U7649.

Dr. Bulcha's primary practice is Beauregard Health System, at 600 S Pine Street, Deridder, LA 70634 in Beauregard Parish. The practice phone is (337) 462-7100.

Dr. Bulcha's primary practice is Beauregard Health System in Deridder, Louisiana, part of Beauregard Parish Police Jury. Dr. Bulcha is also affiliated with Southeast Iowa Regional Medical Center, West Burlington. The medical group on file is Beauregard Health System. Dmand AI also links Dr. Bulcha to 4 more hospitals, 6 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bulcha practices, 7 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Bulcha's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Bulcha is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Bulcha's licenses on file in 7 states: Texas, New Mexico, Oklahoma, Pennsylvania, Iowa, Louisiana and New York.

Dmand AI lists aneurysm, atrial fibrillation and flutter, chronic hypertension, coronary artery disease, heart valve surgery and high cholesterol among the conditions Dr. Bulcha treats.

CMS data shows 894 Medicare services from Dr. Bulcha across 10 procedure codes in 2024, for 610 Medicare patients. Medicare paid $26,493 for them.

CMS counts 610 Medicare patients who saw Dr. Bulcha in 2024. The largest group is 65 to 74, with 219 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bulcha's median patient age at 60, with 56% women.

In 2024, Dr. Bulcha wrote 636 Medicare Part D claims for 187 patients. 85% of them were for generic drugs. CMS names the drug for 498 of them, across 18 drugs with 11 or more claims each, at $72,879 in total drug cost. In 2023, CMS named 47 claims across 3 drugs.

Dr. Bulcha accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 12 procedures of coronary angioplasty and stenting by Dr. Bulcha, more than 33% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Bulcha in 2020. 2020 was the busiest year, with 2. Dr. Bulcha's most frequent co-authors are Anjani Durga Golive, MD, Tanush Gupta, MD and Ulrich Peter Jorde, MD.

CMS Open Payments shows 89 general payments to Dr. Bulcha from 17 drug and device companies from 2021 to 2025. Travel and lodging make up the largest share, 55% of the total. Medtronic, Inc. paid the most, $3,075.

Dmand AI lists 3 awards for Dr. Bulcha, most recently Committee of Interns and Residents Haiti Scholarship in 2017.

Dr. Bulcha is a member of ACC, ACP, AHA, International Society for Heart and Lung Transplantation and Society for Cardiovascular Angiography and Interventions.

Dr. Bulcha is in network with 23 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.